# Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients

> **NCT04736121** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Sirtex Medical** · enrollment: 100 (actual)

## Conditions studied

- Unresectable Hepatocellular Carcinoma
- BCLC Stage A Hepatocellular Carcinoma
- BCLC Stage B Hepatocellular Carcinoma
- BCLC Stage C Hepatocellular Carcinoma

## Interventions

- **DEVICE:** Resin microspheres containing yttrium-90 (Y-90)

## Key facts

- **NCT ID:** NCT04736121
- **Lead sponsor:** Sirtex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-28
- **Primary completion:** 2025-08-14
- **Final completion:** 2026-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04736121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04736121, "Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04736121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*